Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study.

Guo X, Zhai J, Liu Z, Fang M, Wang B, Wang C, Hu B, Sun X, Lv L, Lu Z, Ma C, He X, Guo T, Xie S, Wu R, Xue Z, Chen J, Twamley EW, Jin H, Zhao J.

Arch Gen Psychiatry. 2010 Sep;67(9):895-904. doi: 10.1001/archgenpsychiatry.2010.105.

2.

Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study.

Kang R, Wu Y, Li Z, Jiang J, Gao Q, Yu Y, Gao K, Yan Y, He Y.

Psychopathology. 2016;49(5):345-355.

PMID:
27584836
3.

Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.

Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT.

Arch Gen Psychiatry. 2012 Feb;69(2):121-7. doi: 10.1001/archgenpsychiatry.2011.129.

PMID:
21969420
4.

Cost-effectiveness analysis of psychosocial intervention for early stage schizophrenia in China: a randomized, one-year study.

Zhang Z, Zhai J, Wei Q, Qi J, Guo X, Zhao J.

BMC Psychiatry. 2014 Jul 26;14:212. doi: 10.1186/s12888-014-0212-0.

5.

Adjunctive psychosocial therapies for the treatment of schizophrenia.

Patterson TL, Leeuwenkamp OR.

Schizophr Res. 2008 Mar;100(1-3):108-19. doi: 10.1016/j.schres.2007.12.468. Review.

PMID:
18226500
6.

Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.

Subotnik KL, Casaus LR, Ventura J, Luo JS, Hellemann GS, Gretchen-Doorly D, Marder S, Nuechterlein KH.

JAMA Psychiatry. 2015 Aug;72(8):822-9. doi: 10.1001/jamapsychiatry.2015.0270.

7.

Supplementing clinic-based skills training with manual-based community support sessions: effects on social adjustment of patients with schizophrenia.

Glynn SM, Marder SR, Liberman RP, Blair K, Wirshing WC, Wirshing DA, Ross D, Mintz J.

Am J Psychiatry. 2002 May;159(5):829-37.

PMID:
11986138
8.

Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.

Chien WT, Mui JH, Cheung EF, Gray R.

Trials. 2015 Jun 14;16:270. doi: 10.1186/s13063-015-0785-z.

9.

Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.

Moritz S, Veckenstedt R, Andreou C, Bohn F, Hottenrott B, Leighton L, Köther U, Woodward TS, Treszl A, Menon M, Schneider BC, Pfueller U, Roesch-Ely D.

JAMA Psychiatry. 2014 Oct;71(10):1103-11. doi: 10.1001/jamapsychiatry.2014.1038.

PMID:
25103718
10.

The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.

Valencia M, Fresan A, Juárez F, Escamilla R, Saracco R.

J Psychiatr Res. 2013 Dec;47(12):1886-92. doi: 10.1016/j.jpsychires.2013.09.006.

PMID:
24112947
11.

Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA.

Schizophr Bull. 2009 Mar;35(2):336-46. doi: 10.1093/schbul/sbn067.

12.

Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.

Velligan DI, Bow-Thomas CC, Huntzinger C, Ritch J, Ledbetter N, Prihoda TJ, Miller AL.

Am J Psychiatry. 2000 Aug;157(8):1317-23.

PMID:
10910797
13.

Psychoeducation (brief) for people with serious mental illness.

Zhao S, Sampson S, Xia J, Jayaram MB.

Cochrane Database Syst Rev. 2015 Apr 9;(4):CD010823. doi: 10.1002/14651858.CD010823.pub2. Review.

PMID:
25854522
14.

Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China.

Li ZJ, Guo ZH, Wang N, Xu ZY, Qu Y, Wang XQ, Sun J, Yan LQ, Ng RM, Turkington D, Kingdon D.

Psychol Med. 2015 Jul;45(9):1893-905. doi: 10.1017/S0033291714002992.

PMID:
25532460
15.

Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial.

Chien WT, Mui J, Gray R, Cheung E.

BMC Psychiatry. 2016 Feb 25;16:42. doi: 10.1186/s12888-016-0744-6.

16.

The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia.

Juckel G, Morosini PL.

Curr Opin Psychiatry. 2008 Nov;21(6):630-9. doi: 10.1097/YCO.0b013e328314e144. Review.

PMID:
18852573
17.

Prognostic subgroups for remission, response, and treatment continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial.

Jakubovski E, Carlson JP, Bloch MH.

J Clin Psychiatry. 2015 Nov;76(11):1535-45. doi: 10.4088/JCP.14m09320.

PMID:
26581028
18.

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.

Eur Psychiatry. 2007 Oct;22(7):433-43.

PMID:
17555947
20.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

Items per page

Supplemental Content

Support Center